Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR)

Category Primary study
JournalBreast
Year 2021
This article has no abstract
Epistemonikos ID: d68584598f9e9cd51fc749d101f3a13e5f54ae23
First added on: Feb 14, 2025